Impaired erythrocyte transmembrane potential in diabetes mellitus and its possible improvement by resorcylidene aminoguanidine
- 1 December 2000
- journal article
- Published by Elsevier in Bioelectrochemistry
- Vol. 52 (2) , 251-256
- https://doi.org/10.1016/s0302-4598(00)00107-0
Abstract
No abstract availableKeywords
Funding Information
- Ministerstvo školstva, vedy, výskumu a športu Slovenskej republiky
- Uniwersytet Łódzki
- Vedecká Grantová Agentúra MŠVVaŠ SR a SAV (1/5158/98, 1/6145/99)
This publication has 11 references indexed in Scilit:
- Inhibition of nonenzymatic protein glycation and lipid peroxidation by drugs with antioxidant activityLife Sciences, 1999
- Human red blood cell membrane potential and fluidity in glucose solutionsScandinavian Journal of Clinical and Laboratory Investigation, 1997
- Crystal and molecular structure of β-resorcylidene aminoguanidine copper(II) complexJournal of Chemical Crystallography, 1996
- Antimutagenic and bacteriostatic activities of Schiff‐base compounds derived from aminoguanidine, semicarbazone and thiosemicarbazone and a copper(II)‐coordination complexToxicological & Environmental Chemistry, 1996
- The effect of oxidizing agents and diabetes mellitus on the human red blood cell membrane potentialClinical Biochemistry, 1996
- Antioxidant Status and Lipid Peroxidation in Type II Diabetes Mellitus with and without ComplicationsClinical Science, 1996
- Inhibition of cardiac sarcolemma Na+?K+ ATPase by oxyradical generating systemsMolecular and Cellular Biochemistry, 1995
- Glycation and oxidation: A role in the pathogenesis of atherosclerosisThe American Journal of Cardiology, 1993
- Changes in fluidity and composition of erythrocyte membranes and in composition of plasma lipids in Type I diabetesBritish Journal of Haematology, 1986
- Shape changes of human erythrocytes induced by various amphipathic drugs acting on the membrane of the intact cellsBiochemical Pharmacology, 1979